Healthcare -
Biotechnology - NASDAQ - BM
$ 18.54
0.816 %
$ 1.34 B
Market Cap
-154.5
P/E
KNSA - REVENUE
Revenue KNSA - Kiniksa Pharmaceuticals, Ltd.
270 M
LAST VALUE
164.80%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR